NCT00247312View on ClinicalTrials.gov

Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

319

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Prostatic Neoplasm
Interventions
RADIATION

Pd-103

Trial Locations (2)

26003

Schiffler Cancer Center, Wheeling

98108-1597

Radiation Oncology 174 Department of Veterans Affairs, Seattle

All Listed Sponsors
lead

Schiffler Cancer Center

OTHER

NCT00247312 - Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial | Biotech Hunter | Biotech Hunter